Analgesic Use and Effectiveness for Dental Procedures

October 7, 2016 updated by: Pearl Network

PRL0706: Analgesic Use and Effectiveness

Opioid analgesics prescribed by dentists may contribute to the larger national issue of the use and abuse of the drug. On occasion dental pain may be sufficiently severe to support the use of opioids. This study used both dentist and patient input to evaluate the use of opioid and over-the-counter analgesics following one of seven coded common dental procedures. The study includes a five day patient follow up assessment of the effectiveness of the analgesic. Baseline questionnaires were completed by eligible participants, and they responded to the day 5 follow up questionnaires.

Study Overview

Status

Completed

Conditions

Detailed Description

Specific Aims The overall objective of the proposed study is to determine (1) the pattern of analgesic prescriptions (Rx and OTC) and recommendations (OTC) in dental practices; and (2) the effectiveness of and side effects associated with these medications as measured by patientreported outcomes (PROs).

Specific Aim 1: To document (a) dentists' postprocedural prescriptions and recommendations for analgesic medication: and (b) the effectiveness of these medications and side effects associated with their use as measured by PROs.

Specific Aim 2: To analyze by procedure class and anticipated pain severity the PROs of Rx and OTC analgesic medications.

Specific Aim 3: Determine the incidence of analgesic side effects of Rx and OTC analgesic medications.

The outcomes of Specific Aims 1-3 will be:

  • The distribution of dentists' Rx/OTC prescriptions/recommendations by dentists for anticipated pain severity.
  • The effectiveness of different types of Rx and OTC analgesics (e.g., Rx NSAIDs vs. OTC NSAIDs, Rx NSAIDs vs. Rx narcotics) by procedure class and anticipated pain severity.
  • The incidence of analgesic side effects for Rx and OTC analgesics. Analysis of the results and methods of the proposed research will furthermore serve as guidance in designing a randomized PBRN clinical trial comparing the efficacy of and complications associated with two or more analgesics.

Study Type

Observational

Enrollment (Actual)

2773

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10010
        • PEARL Network Sites

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Practice-based study. Patients recruited from the practice sites of PEARL Network dentists.

Description

Inclusion Criteria:

  1. Presence of erupted second molar teeth.
  2. Scheduled for treatment in one procedure of the following six procedure classes:

    extraction, endodontic therapy, pulp capping, crown preparation, periodontal surgery, abscess treatment

  3. Expected by the P-I to experience postoperative pain sufficient to require an analgesic
  4. Permanent dentition (erupted 2nd molar teeth)
  5. Capacity to judge pain level
  6. Ability and willingness to give verbal consent

Exclusion Criteria:

  1. Under treatment for medical disorders, including dementia, Parkinson's disease, depression, severe anxiety, or any other medical condition, that, in the opinion of the P-I, would affect the subject's judgment of postoperative pain
  2. Current participation in another dental or medical research study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dentist questionnaire
Time Frame: baseline
dentists' postprocedural prescriptions were recorded by analgesic class: Opioid, NSAID, or other (Descriptive measures)
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dentist questionnaire - anticipated pain by patients using VAS-5 pain scale
Time Frame: 5 days after the dental procedure
anticipated pain severity using the VAS-5 pain scale (1-5 scale)
5 days after the dental procedure
Patient questionnaire - OHIP-14 patient reported outcomes quality of life survey (questionnaire).
Time Frame: 5 days after the dental procedure
5 days after the dental procedure

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient questionnaire - side effects of analgesics post dental procedure
Time Frame: 5 days post dental procedure
(Descriptive methods were used) to determine side effects: Yes/no, describe for Rx and OTC analgesic medications.
5 days post dental procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Frederick A Curro, DMD, PhD, Pearl Network

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2007

Primary Completion (Actual)

November 1, 2011

Study Completion (Actual)

June 1, 2014

Study Registration Dates

First Submitted

February 5, 2016

First Submitted That Met QC Criteria

October 7, 2016

First Posted (Estimate)

October 11, 2016

Study Record Updates

Last Update Posted (Estimate)

October 11, 2016

Last Update Submitted That Met QC Criteria

October 7, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • PRL0706
  • U01DE016755 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Will send to the NIDCR.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Subscribe